Expression of cyclin E and cyclin-dependent kinase 2 correlates with metastasis and prognosis in colorectal carcinoma

Human Pathology

Volumn 32, Issue 9, 2001, Pages 945-953

  Li, Jia Qing ^a   Miki, Hiroshi ^a   Ohmori, Masaki ^a   Wu, Fei ^a   Funamoto, Yasunobu ^a  

^a KAGAWA UNIVERSITY   (Japan)

Author keywords

Colorectal carcinoma; Cyclin E; Cyclin dependent kinase; Metastasis

Indexed keywords

ANTIBODY; CYCLIN DEPENDENT KINASE 2; CYCLIN E;

ADENOMA; ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER INFILTRATION; CANCER STAGING; CHEMOTHERAPY; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS; MUCINOUS CARCINOMA; PERITONEUM METASTASIS; POLYP; PROGNOSIS; PROTEIN EXPRESSION; TUMOR VOLUME;

EID: 0034813673     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1053/hupa.2001.27116     Document Type: Article

References (34)

1. Cancer cell cycles
2. Role of the cyclin-dependent kinase inhibitors in the development of cancer
3. Different roles for cyclins D1 and E in regulation of the G1-to-S transition
4. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition
5. Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system
6. Formation and activation of a cyclin E-cdk 2 complex during the G1 phase of the human cell cycle
7. Processing of cyclin E differs between normal and tumor breast cells
8. Concurrent overexpression of cyclin D1 and cyclin-dependent kinase 4 (Cdk4) in intestinal adenomas from multiple intestinal neoplasia (Min) mice and human familial adenomatous polyposis patients
9. Expression of cell cycle control proteins in primary colorectal tumors does not always predict expression in lymph node metastases
10. Expression of p21WAF1/CIP 1 in colorectal adenomas and adenocarcinomas and its correlation with p53 protein expression
11. Down-regulation of p27 is associated with development of colorectal adenocarcinoma metastases
12. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p 27 in aggressive colorectal carcinomas
13. Expression of cyclin E in colorectal adenomas and adenocarcinomas: Correlation with expression of Ki-67 antigen and p53 protein
14. Coexpression of cdk2/cdc2 and retinoblastoma gene products in colorectal cancer
15. Cdk2/cdc2 expression in colon carcinogenesis and effects of cdk2/cdc2 inhibitor in colon cancer cells
16. Tumor angiogenesis in primary and metastatic colorectal cancers
17. Therapeutic opportunities from tumour biology in metastatic colon cancer
18. Proliferation and apoptosis in proliferative lesions of the colon and rectum
19. Comparison of different monoclonal antibodies for the immunohistochemical assessment of cell proliferation in routine colorectal biopsy specimens
20. Active cyclin A-CDK2 complex, a possible critical factor for cell proliferation in human primary lung carcinomas
21. Immunohistochemical analysis of cell kinetic parameters in colonic adenocarcinomas, adenomas, and normal mucosa
22. Amplified CDK2 and cdc2 activities in primary colorectal carcinoma
23. Apoptosis occurs more frequently in metastatic foci than in primary lesions of human colorectal carcinomas: Analysis by terminal-deoxynucleotidyl-transferase-mediated dUTP-biotin nick end labeling
24. p27kipI: A multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers
25. First steps of tumor-related angiogenesis
26. Possible paracrine mechanism of insulin-like growth factor- 2 in the development of liver metastases from colorectal carcinoma
27. Loss of cell cycle regulators p27(Kip1) and cyclin E in transitional cell carcinoma of the bladder correlates with tumor grade and patient survival
28. Prognostic value of cyclin E and p 53 expression in gastric carcinoma
29. Expression of cell-cycle regulators p27Kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients
30. Concurrent amplification of cyclin E and CDK 2 genes in colorectal carcinomas
31. Role of p27Kip1 and cyclin-dependent kinase 2 in the proliferation of non-small cell lung cancer
32. Flavopiridol, a novel cyclin-dependent kinase inhibitor, in metastatic renal cancer: A University of Chicago phase II consortium study
33. Cancer dormancy: Role of cyclin-dependent kinase inhibitors in induction of cell cycle arrest mediated via membrane IgM
34. Characterisation of the G1/S cell cycle checkpoint defect in lung carcinoma cells with different intrinsic radiosensitivities